The EORTC Early Clinical Trials Cooperative Group experience with 5 aza 2' deorycytidine (NSC 1227716) in patients with colorectal, head and neck, renal carcinomas and malignant melanomas

R. Abele, M. Clavel, P. Dodion, U. Bruntsch, S. Gundersen, J. Smyth, J. Renard, M. van Glabbeke, H.M. Pinedo

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1921-1924
JournalEuropean Journal of Cancer and Clinical Oncology
Volume23
Publication statusPublished - 1987

Cite this